Psychedelic-assisted psychotherapy and its potential to manage demoralization: A brief exploration of an alternative approach to end of life care
May 7, 2025 Jennifer Ong
Australia has become the first country to approve MDMA and psilocybin for clinical treatment of post-traumatic stress disorder and treatment-resistant depression. This article explores the history of psychedelic use, how these substances work, and the hope they may offer people receiving end-of-life care.